The Changing Face of HIV

Gallo RC , Montagnier L. The chronology of AIDS research. Nature. 1987; 326: 435–436.

Walensky RP , Paltiel AD , Losina E. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006; 194: 11–19.

Palella FJ Jr. , Delaney KM , Moorman AC. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338: 853–860.

Coffin JM. Genetic variation in AIDS viruses. Cell. 1986; 46: 1–4.

Johnson VA , Brun-Vezinet F , Clotet B. Update of the drug resistance mutations in HIV-1: 2006. Top HIV Med. 2005; 14: 125–130.

DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents—A working group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. October 10, 2006.

Bangsberg DR , Acosta EP , Gupta R. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006; 20: 223–231.

Braithwaite RS , Shechter S , Roberts MS. Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation. J Antimicrob Chemother. 2006; 58: 1036–1043.

Mugavero M , Ostermann J , Whetten K. Barriers to anti-retroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS. 2006; 20: 418–428.

Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Vol. 17. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2006. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Accessed May 24, 2007.

Centers for Disease Control and Prevention. Epidemiology of HIV/AIDS—United States, 1981-2005. MMWR Morb Mortal Wkly Rpt. 2006; 55: 589–592.